- Home
- XP vs RVTY Comparison
XP vs RVTY Comparison
Compare XP & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XP | RVTY |
|---|---|---|
| Founded | 2001 | 1937 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 11.8B |
| IPO Year | 2019 | 1994 |
Fundamental Metrics
Financial Performance| Metric | XP | RVTY |
|---|---|---|
| Price | $19.23 | $91.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 15 |
| Target Price | $22.67 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 6.5M | 1.2M |
| Earning Date | 01-01-0001 | 04-27-2026 |
| Dividend Yield | ★ 0.97% | 0.31% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $19.15 | $6.34 |
| Revenue Next Year | $13.67 | $5.10 |
| P/E Ratio | ★ $11.42 | $44.32 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.20 | $81.36 |
| 52 Week High | $23.13 | $119.02 |
Technical Indicators
Market Signals| Indicator | XP | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 45.56 | 35.92 |
| Support Level | $18.05 | $88.42 |
| Resistance Level | $20.37 | $95.99 |
| Average True Range (ATR) | 1.07 | 3.24 |
| MACD | -0.37 | -0.39 |
| Stochastic Oscillator | 22.38 | 23.39 |
Price Performance
Historical ComparisonAbout XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.